Search results
Results from the WOW.Com Content Network
Chi Van Dang is a hematological oncologist and researcher, currently serving as the Scientific Director of Ludwig Institute for Cancer Research. [1] He is known for his research on genetics, the MYC gene and the cellular energy metabolism of cancer. Dang has served as president of the American Society for Clinical Investigation. [2]
UCSF Helen Diller Medical Center at Parnassus Heights is located on the main campus of UCSF and includes the 600-bed teaching hospital of the same name along with the Langley Porter Psychiatric Institute, extensive research labs, the main branch of the UCSF Library, and is home to the UCSF School of Medicine, UCSF School of Nursing, UCSF School of Dentistry, and UCSF School of Pharmacy.
Paul L. Nguyen is an American radiation oncologist and researcher specializing in prostate cancer research and clinical care. Nguyen has worked with the Dana–Farber Cancer Institute, the Brigham and Women's Hospital, and Harvard Medical School, and his research has sought to assess the effectivity of hormone-targeted therapy in treating prostate cancer, the importance of social systems like ...
On June 5, 2015, surgeons at CPMC and University of California, San Francisco successfully completed 18 surgeries in the nation's first nine-way, two-day kidney transplant chain in a single city. [49] [50] [51]
He currently works at San Francisco General Hospital. Prasad is currently a full professor of hematology-oncology at UCSF. [4] He is a cancer drug and health policy researcher. He also studies the financial conflicts in drug approvals. [5] In 2015, Prasad published the book, Ending Medical Reversal, with physician and academic Adam Cifu. [6]
The facade of the now-demolished 1924 hospital. The 1979 annex stands uphill. A site was acquired to expand the existing dispensary on Trenton in 1920, and the Chinese Six Companies convened a meeting of 15 community organizations, who boldly decided to build a modern hospital instead, which would require extensive fundraising; the 15 organizations met again in October 1922, forming the ...
Hope S. Rugo is professor of medicine and the director of the breast oncology clinical trials program at the University of California at San Francisco, and an investigator of SPORE (Specialized Program of Research Excellence in Breast Cancer) in the Bay Area. [1] In 2014 Rugo chaired the advisory panel of OncLive's "Giants of Cancer Care" award ...
Champions Oncology is an American technology company that develops mouse avatars.Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients.